We respond to provisional rejection of trastuzumab deruxtecan (Enhertu) for certain secondary breast cancer patients
Baroness Delyth Morgan, chief executive at Breast Cancer Now, said:
26 Sept 2023
We respond to July’s cancer waiting times from NHS Wales
Melanie Sturtevant, associate director of policy, evidence and influencing at Breast Cancer Now, said:
21 Sept 2023
We respond to July’s NHS England waiting times data
Baroness Delyth Morgan, chief executive at Breast Cancer Now, said:
14 Sept 2023
We respond to new CRUK analysis revealing over a million lives have been saved over last four decades in the UK due to advances in cancer care
Baroness Delyth Morgan, chief executive at Breast Cancer Now, said:
01 Sept 2023
Breast Cancer Now respond to latest NHSE announcement of changes to cancer standards targets
Dr Simon Vincent, director of research, support and influencing at Breast Cancer Now, said:
17 Aug 2023
We respond to research identifying new rare genes associated with breast cancer
In response to new research published in Nature Genetics which identifies new, rare genes associated with breast cancer, Dr Kotryna Temcinaite, head of research communications at Breast Cancer Now, said:
17 Aug 2023
We respond to findings from a Swedish trial about AI supported breast screening
In response to interim findings from a Swedish randomised control trial about AI-supported breast screening published in Lancet Oncology, Dr Kotryna Temcinaite, head of research communications at Breast Cancer Now, said:
02 Aug 2023
Breast Cancer Now responds to the decision by NICE to provisionally reject talazoparib (Talzenna)
Baroness Delyth Morgan, chief executive of Breast Cancer Now, said:
28 Jul 2023
Breast Cancer Now respond to latest NHS Workforce Plan
Responding to the publication of the NHS long-term workforce plan, Baroness Delyth Morgan, chief executive at Breast Cancer Now, said:
30 Jun 2023
Breast Cancer Now responds to news of Sarah, the Duchess of York's breast cancer diagnosis
In response to the news of Sarah, Duchess of York’s breast cancer diagnosis, Addie Mitchell, clinical nurse specialist at Breast Cancer Now, said:
26 Jun 2023
We respond to the publication of a new 10-year Cancer Strategy in Scotland
Baroness Delyth Morgan, chief executive at Breast Cancer Now, said:
15 Jun 2023
New research reveals most women diagnosed with early-stage breast cancer can expect to become “long-term survivors”
Baroness Delyth Morgan, chief executive at Breast Cancer Now said:
13 Jun 2023